LCTX earnings: a positive outcome, +6.4%

On November 10, 2022, Lineage Cell Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +6.4% in the window around the event. It had already run +12.2% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.